Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
I C Robinson, R G Clar. Growth promoting activity of IGF-I in the rat. Acta paediatrica Scandinavica. Supplement. vol 347. 1989-08-14. PMID:3075842. |
growth arrest in the diabetic rat was corrected by insulin infusion which also restored gh secretion. |
1989-08-14 |
2023-08-11 |
rat |
M Kjaer, N H Secher, F W Bach, S Sheikh, H Galb. Hormonal and metabolic responses to exercise in humans: effect of sensory nervous blockade. The American journal of physiology. vol 257. issue 1 Pt 1. 1989-08-11. PMID:2546439. |
during exercise, responses of catecholamines, insulin, glucagon, and growth hormone (gh) in plasma as well as glucose production and utilization, plasma free fatty acids, and plasma glycerol were similar in epidural and control experiments (p greater than 0.05). |
1989-08-11 |
2023-08-11 |
Not clear |
M Kjaer, N H Secher, F W Bach, S Sheikh, H Galb. Hormonal and metabolic responses to exercise in humans: effect of sensory nervous blockade. The American journal of physiology. vol 257. issue 1 Pt 1. 1989-08-11. PMID:2546439. |
afferent nervous activity is probably less important than efferent activity from motor centers for responses of gh, catecholamines and insulin, and, in turn, extramuscular fuel mobilization in exercise. |
1989-08-11 |
2023-08-11 |
Not clear |
Z J Sun, X H Huang, J H Tan. [Study on the mechanism of glucose intolerance and insulin resistance in epidemic hemorrhagic fever]. Zhonghua nei ke za zhi. vol 28. issue 2. 1989-08-10. PMID:2567660. |
23 patients had impaired glucose tolerance, 17 patients showed hyperinsulinemia in fasting state, 12 patients had flat insulin response curves and most patients had higher plasma levels of growth hormone (gh), cortisol (f), norepinephrine (ne) and epinephrine (e) in critical stage than in convalescent stage. |
1989-08-10 |
2023-08-11 |
Not clear |
Z J Sun, X H Huang, J H Tan. [Study on the mechanism of glucose intolerance and insulin resistance in epidemic hemorrhagic fever]. Zhonghua nei ke za zhi. vol 28. issue 2. 1989-08-10. PMID:2567660. |
these data suggest that in ehf there are disturbed glucose metabolism and insulin resistance due to decreased pancreatic b cell reservoir and increased insulin antagonists such as gh, f, ne, e etc. |
1989-08-10 |
2023-08-11 |
Not clear |
S A Zinn, L T Chapin, W J Enright, H A Tucke. Failure of photoperiod to alter body growth and carcass composition in beef steers. Journal of animal science. vol 67. issue 5. 1989-08-03. PMID:2661514. |
on d 155, compared with lpn, hpn increased (p less than .01) serum insulin (ins; 1.09 vs .64 ng/ml) and lowered (p less than .05) growth hormone (gh; 2.14 vs 3.70 ng/ml), but prolactin was not affected. |
1989-08-03 |
2023-08-11 |
Not clear |
H Sakuma, S Takase, Y Mizuno, K Teramura, K Hane. Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy. The Tohoku journal of experimental medicine. vol 156. issue 3. 1989-08-01. PMID:3252557. |
we studied the function of hypothalamo-pituitary dopaminergic system in 15 myotonic dystrophy (myd) patients whose growth hormone (gh) responses to insulin or arginine had been normal. |
1989-08-01 |
2023-08-11 |
Not clear |
J L Sartin, F F Bartol, R J Kemppainen, G Dieberg, D Buxton, E Soyool. Modulation of growth hormone-releasing factor stimulated growth hormone secretion by plasma glucose and free fatty acid concentrations in sheep. Neuroendocrinology. vol 48. issue 6. 1989-07-27. PMID:3150778. |
in experiment 1, the effects of an infusion of insulin (0.025 u/kg bw.h-1), glucose (40 mg/kg bw.h-1), insulin plus glucose or saline on the subsequent effects of bgrf on plasma gh concentrations were determined. |
1989-07-27 |
2023-08-11 |
cattle |
M Hernández, J Fragoso, R Barrio, J Argente, E Arill. Subcutaneous treatment with growth hormone-releasing hormone for short stature. Hormone research. vol 30. issue 6. 1989-07-21. PMID:2907992. |
in the present study we report the effects of therapy with growth hormone-releasing factor (1-29)nh2 (grf) on growth rate, plasma levels of insulin growth factor i (igf-i) and growth hormone (gh) secretion in 11 children who were selected solely on the basis of their short stature and normal gh secretion on standard provocative tests. |
1989-07-21 |
2023-08-11 |
Not clear |
M Bozzola, A Valtorta, A Moretta, D Montagna, R Maccario, G R Burgi. Modulating effect of growth hormone (GH) on PHA-induced lymphocyte proliferation. Thymus. vol 12. issue 3. 1989-07-21. PMID:3075099. |
in order to investigate the ability of growth hormone (gh) to modulate lymphoproliferation, peripheral blood mononuclear cells (pbmc) from healthy adults were stimulated with phytohaemagglutinin (pha) in the presence of increasing concentrations of pituitary (crescormon) and biosynthetic (somatonorm and genotropin) gh (from 0.425 x 10(3) to 501.5 x 10(3) ng/ml) as well as biosynthetic insulin (rhinsulin, humulin 1 eli lilly: from 0.0012 to 20 u/ml). |
1989-07-21 |
2023-08-11 |
Not clear |
R N Kirkwood, P A Thacker, B Laarvel. The influence of growth hormone injections on the endocrine and metabolic status of gilts. Domestic animal endocrinology. vol 6. issue 2. 1989-07-20. PMID:2499441. |
growth hormone treatment reduced serum concentrations of t4 (p less than 0.001) and prolactin (p less than 0.02), but increased serum gh (p less than 0.001), t3 (p less than 0.06), insulin (p less than 0.001) and glucose (p less than 0.001). |
1989-07-20 |
2023-08-11 |
Not clear |
R N Kirkwood, P A Thacker, B Laarvel. The influence of growth hormone injections on the endocrine and metabolic status of gilts. Domestic animal endocrinology. vol 6. issue 2. 1989-07-20. PMID:2499441. |
the concomitant elevation of serum insulin and glucose suggests that an insulin-resistant state was induced which, if evident at the ovarian level, may be a factor mediating the adverse effects of exogenous gh on ovarian function. |
1989-07-20 |
2023-08-11 |
Not clear |
H Ronge, J Blu. Insulin-like growth factor I responses to recombinant bovine growth hormone during feed restriction in heifers. Acta endocrinologica. vol 120. issue 6. 1989-07-11. PMID:2658455. |
gh, insulin-like growth factor i and insulin increased, whereas urea-nitrogen decreased in response to exogenous gh when heifers were adequately fed (p less than 0.05). |
1989-07-11 |
2023-08-11 |
cattle |
H Ronge, J Blu. Insulin-like growth factor I responses to recombinant bovine growth hormone during feed restriction in heifers. Acta endocrinologica. vol 120. issue 6. 1989-07-11. PMID:2658455. |
therefore, during insufficient energy and (or) protein intake, characterized by low glucose, insulin and thyroid hormone levels and increased non-esterified fatty acid concentrations, insulin-like growth factor i concentrations and responses to gh administration were markedly reduced. |
1989-07-11 |
2023-08-11 |
cattle |
A C Lerario, W el-Andere, B L Wajchenberg, L Y Ohnuma, M H Rocha, A Andriol. Insulin resistance in acromegaly: evaluation by studies of insulin binding to erythrocytes. Journal of endocrinological investigation. vol 12. issue 3. 1989-07-05. PMID:2656831. |
basal growth hormone concentrations were elevated in all acromegalic patients, but no correlation was observed between insulin and gh levels. |
1989-07-05 |
2023-08-11 |
human |
J Zapf, C Hauri, M Waldvogel, E Futo, H Häsler, K Binz, H P Guler, C Schmid, E R Froesc. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proceedings of the National Academy of Sciences of the United States of America. vol 86. issue 10. 1989-06-28. PMID:2471192. |
they are induced by gh and insulin, respectively, and appear in the 200-kda complex. |
1989-06-28 |
2023-08-11 |
human |
K Osei, T M O'Dorisio, W B Malarkey, E L Craig, S Catalan. Metabolic effects of long-acting somatostatin analogue (sandostatin) in type I diabetic patients on conventional therapy. Diabetes. vol 38. issue 6. 1989-06-27. PMID:2656340. |
twenty-four-hour serum glucose, free insulin, plasma growth hormone (gh), and glucagon profiles were obtained before and during treatment at 4-wk intervals. |
1989-06-27 |
2023-08-11 |
Not clear |
K Osei, T M O'Dorisio, W B Malarkey, E L Craig, S Catalan. Metabolic effects of long-acting somatostatin analogue (sandostatin) in type I diabetic patients on conventional therapy. Diabetes. vol 38. issue 6. 1989-06-27. PMID:2656340. |
basal and postprandial glucose, free insulin, gh, and glucagon profiles were not influenced by the sms 201-995 therapy throughout the study. |
1989-06-27 |
2023-08-11 |
Not clear |
A Alvestrand, M Mujagic, A Wajngot, S Efendi. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance. Clinical nephrology. vol 31. issue 4. 1989-06-22. PMID:2565775. |
in contrast, insulin resistance was present to a similar degree in uremic subjects of group u:n, u:bl and u:d. during sigit endogenous insulin, glucagon and growth hormone (gh) were suppressed in both uremic and control subjects. |
1989-06-22 |
2023-08-11 |
human |
A Alvestrand, M Mujagic, A Wajngot, S Efendi. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance. Clinical nephrology. vol 31. issue 4. 1989-06-22. PMID:2565775. |
this implies that insulin resistance in uremia is most likely not due to hyperglucagonemia or abnormal gh metabolism. |
1989-06-22 |
2023-08-11 |
human |